Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10316002 Kinase inhibitors for the treatment of disease

Patent 10316002 was granted and assigned to Dana-Farber Cancer Institute on June, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 28 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12071432 Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof
0
Edits on 9 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 9 Dec, 2023
Edits made to:
Article (+292 characters)
Article

Patent abstract

The invention relates to compounds and their use in the treatment of disease. Novel irreversible inhibitors of wild-type and mutant forms of EGFR, FGFR, ALK, ROS, JAK, BTK, BLK, ITK, TEC, and/or TXK and their use for the treatment of cell proliferation disorders are described.

Edits on 2 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2023
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Hwan Geun Choi0
Li Tan0
Nathanael Gray0
Edits on 23 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=103160020
Edits on 22 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Apr, 2023
Edits on 29 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
103160020
Date of Patent
June 11, 2019
0
Patent Application Number
156963090
Date Filed
September 6, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=103160020
Patent Citations Received
‌
US Patent 10906878 Kinase inhibitors for the treatment of disease
0
‌
US Patent 11390611 Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
0
‌
US Patent 11518758 Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
0
‌
US Patent 11530206 Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof
0
‌
US Patent 11590134 Aminopyrimidine amide autophagy inhibitors and methods of use thereof
0
Patent Primary Examiner
‌
Alexander R Pagano
0
Edits on 29 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Edits on 1 Mar, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 Mar, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11590134 Aminopyrimidine amide autophagy inhibitors and methods of use thereof
0
Edits on 21 Dec, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Dec, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11530206 Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof
0
Edits on 7 Dec, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11518758 Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
0
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 24 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Edits on 20 Jul, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 20 Jul, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11390611 Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10316002
Edits on 9 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10906878 Kinase inhibitors for the treatment of disease
Edits on 26 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 26 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10316002 Kinase inhibitors for the treatment of disease

Infobox
Is a
Patent
Patent
Patent applicant
Current assignee
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10316002
Date of patent
June 11, 2019
Patent application number
15696309
Date Filed
September 6, 2017
Patent primary examiner
‌
Alexander R Pagano

Find more entities like US Patent 10316002 Kinase inhibitors for the treatment of disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.